323 related articles for article (PubMed ID: 18277855)
41. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis.
Oberholzer A; Souza SM; Tschoeke SK; Oberholzer C; Abouhamze A; Pribble JP; Moldawer LL
Shock; 2005 Jun; 23(6):488-93. PubMed ID: 15897799
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction.
Andrié RP; Becher UM; Frommold R; Tiyerili V; Schrickel JW; Nickenig G; Schwab JO
Crit Care; 2012 Aug; 16(4):R152. PubMed ID: 22889197
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis.
Miguel-Bayarri V; Casanoves-Laparra EB; Pallás-Beneyto L; Sancho-Chinesta S; Martín-Osorio LF; Tormo-Calandín C; Bautista-Rentero D
Med Intensiva; 2012 Nov; 36(8):556-62. PubMed ID: 22495097
[TBL] [Abstract][Full Text] [Related]
44. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
[TBL] [Abstract][Full Text] [Related]
45. Prognostic value of procalcitonin in children with meningococcal sepsis.
Carrol ED; Newland P; Thomson AP; Hart CA
Crit Care Med; 2005 Jan; 33(1):224-5. PubMed ID: 15644674
[TBL] [Abstract][Full Text] [Related]
46. Endothelial cell-specific molecule-1/endocan: Diagnostic and prognostic value in patients suffering from severe sepsis and septic shock.
Pauly D; Hamed S; Behnes M; Lepiorz D; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
J Crit Care; 2016 Feb; 31(1):68-75. PubMed ID: 26489483
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study.
Rau BM; Frigerio I; Büchler MW; Wegscheider K; Bassi C; Puolakkainen PA; Beger HG; Schilling MK
Arch Surg; 2007 Feb; 142(2):134-42. PubMed ID: 17309964
[TBL] [Abstract][Full Text] [Related]
48. Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome.
Tolppanen H; Rivas-Lasarte M; Lassus J; Sadoune M; Gayat E; Pulkki K; Arrigo M; Krastinova E; Sionis A; Parissis J; Spinar J; Januzzi J; Harjola VP; Mebazaa A;
Crit Care Med; 2017 Jul; 45(7):e666-e673. PubMed ID: 28403119
[TBL] [Abstract][Full Text] [Related]
49. New horizons: NT-proBNP for risk stratification of patients with shock in the intensive care unit.
Hoffmann U; Borggrefe M; Brueckmann M
Crit Care; 2006; 10(2):134. PubMed ID: 16594987
[TBL] [Abstract][Full Text] [Related]
50. Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock.
Park DW; Kwak DS; Park YY; Chang Y; Huh JW; Lim CM; Koh Y; Song DK; Hong SB
J Crit Care; 2014 Oct; 29(5):882.e5-11. PubMed ID: 24961965
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
Weber M; Hausen M; Arnold R; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C
Int J Cardiol; 2008 Jul; 127(3):321-7. PubMed ID: 18055041
[TBL] [Abstract][Full Text] [Related]
52. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial.
Oliveira CF; Botoni FA; Oliveira CR; Silva CB; Pereira HA; Serufo JC; Nobre V
Crit Care Med; 2013 Oct; 41(10):2336-43. PubMed ID: 23921272
[TBL] [Abstract][Full Text] [Related]
53. What does high NT-proBNP mean in septic shock patients? A part of the puzzle.
Roch A
Crit Care; 2007; 11(2):122. PubMed ID: 17442126
[TBL] [Abstract][Full Text] [Related]
54. N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients.
Piechota M; Banach M; Irzmański R; Misztal M; Rysz J; Barylski M; Piechota-Urbańska M; Kowalski J; Pawlicki L
Cell Mol Biol Lett; 2007; 12(2):162-75. PubMed ID: 17149558
[TBL] [Abstract][Full Text] [Related]
55. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
[TBL] [Abstract][Full Text] [Related]
56. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
[TBL] [Abstract][Full Text] [Related]
57. Serum N-terminal pro-brain natriuretic peptide level is a significant prognostic factor in patients with severe sepsis among Southwest Chinese population.
Zhang XH; Dong Y; Chen YD; Zhou P; Wang JD; Wen FQ
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):517-21. PubMed ID: 23467952
[TBL] [Abstract][Full Text] [Related]
58. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
[TBL] [Abstract][Full Text] [Related]
59. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.
Fu S; Xie L; Li D; Ye P; Luo L
Clin Interv Aging; 2015; 10():359-65. PubMed ID: 25670892
[TBL] [Abstract][Full Text] [Related]
60. Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.
Masson S; Latini R
Am J Cardiol; 2008 Feb; 101(3A):56-60. PubMed ID: 18243860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
